ProShare Advisors’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $73.3K | Sell |
30,406
-17,568
| -37% | -$42.3K | ﹤0.01% | 1933 |
|
|
2025
Q1 | $106K | Sell |
47,974
-7,514
| -14% | -$16.6K | ﹤0.01% | 1820 |
|
|
2024
Q4 | $302K | Buy |
55,488
+26,251
| +90% | +$143K | ﹤0.01% | 1624 |
|
|
2024
Q3 | $243K | Buy |
+29,237
| New | +$243K | ﹤0.01% | 1609 |
|
|
2023
Q1 | – | Sell |
-12,538
| Closed | -$179K | – | 1865 |
|
|
2022
Q4 | $179K | Sell |
12,538
-266
| -2% | -$3.81K | ﹤0.01% | 1521 |
|
|
2022
Q3 | $327K | Buy |
12,804
+785
| +7% | +$20K | ﹤0.01% | 1097 |
|
|
2022
Q2 | $342K | Sell |
12,019
-4,075
| -25% | -$116K | ﹤0.01% | 1138 |
|
|
2022
Q1 | $568K | Sell |
16,094
-5,159
| -24% | -$182K | ﹤0.01% | 1200 |
|
|
2021
Q4 | $891K | Buy |
+21,253
| New | +$891K | ﹤0.01% | 1096 |
|